BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33667583)

  • 1. High incidence of esophageal fistula on patients with clinical T4b esophageal squamous cell carcinoma who received chemoradiotherapy: A retrospective analysis.
    Chen B; Deng M; Yang C; Dragomir MP; Zhao L; Bai K; Xi M; Hu Y; Zhu Y; Li Q
    Radiother Oncol; 2021 May; 158():191-199. PubMed ID: 33667583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study.
    Kawakami T; Tsushima T; Omae K; Ogawa H; Shirasu H; Kito Y; Yoshida Y; Hamauchi S; Todaka A; Machida N; Yokota T; Yamazaki K; Fukutomi A; Onozawa Y; Yasui H
    BMC Cancer; 2018 May; 18(1):573. PubMed ID: 29776344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.
    Tsuchiya N; Kunisaki C; Sato S; Tanaka Y; Sato K; Watanabe J; Takeda K; Kosaka T; Akiyama H; Endo I
    Langenbecks Arch Surg; 2022 Aug; 407(5):1911-1921. PubMed ID: 35230525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete response to definitive chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma.
    Habu T; Kumanishi R; Ogata T; Fujisawa T; Mishima S; Kotani D; Kadowaki S; Nakamura M; Hojo H; Fujiwara H; Kumagai S; Koyama S; Fujita T; Kinoshita T; Nishikawa H; Yano T; Tajika M; Muro K; Mitsunaga S; Kojima T; Bando H
    Esophagus; 2023 Jul; 20(3):533-540. PubMed ID: 36750480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma.
    Wu H; Yu Y; Zheng Q; Liu T; Wu Y; Wang Z; Zheng H; Liu L; Li J
    Radiat Oncol; 2021 Oct; 16(1):207. PubMed ID: 34717670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Esophageal Fistula Associated With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Cancer: A Supplementary Analysis of JCOG0303.
    Tsushima T; Mizusawa J; Sudo K; Honma Y; Kato K; Igaki H; Tsubosa Y; Shinoda M; Nakamura K; Fukuda H; Kitagawa Y;
    Medicine (Baltimore); 2016 May; 95(20):e3699. PubMed ID: 27196482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma.
    Ochi M; Murakami Y; Nishibuchi I; Kubo K; Imano N; Takeuchi Y; Kimura T; Hamai Y; Emi M; Okada M; Nagata Y
    J Radiat Res; 2021 Jan; 62(1):142-148. PubMed ID: 33392619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma.
    Pao TH; Chen YY; Chang WL; Chang JS; Chiang NJ; Lin CY; Lai WW; Tseng YL; Yen YT; Chung TJ; Lin FC
    PLoS One; 2021; 16(5):e0251811. PubMed ID: 33989365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy.
    Zhang J; Jiao Q; Kong L; Yu J; Fang A; Li M; Yu J
    Thorac Cancer; 2018 Jun; 9(6):726-735. PubMed ID: 29675925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy.
    Zhang T; Guo Z; Chen X; Dong J; Jiang H; Tang P; Wang P; Qian D; Zhang W; Pang Q
    Radiat Oncol; 2022 Aug; 17(1):148. PubMed ID: 35999608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma.
    Barbetta A; Hsu M; Tan KS; Stefanova D; Herman K; Adusumilli PS; Bains MS; Bott MJ; Isbell JM; Janjigian YY; Ku GY; Park BJ; Wu AJ; Jones DR; Molena D
    J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2710-2721.e3. PubMed ID: 29548582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment Esophageal Wall Thickness Associated with Response to Chemoradiotherapy in Locally Advanced Esophageal Cancer.
    Wongwaiyut K; Ruangsin S; Laohawiriyakamol S; Leelakiatpaiboon S; Sangthawan D; Sunpaweravong P; Sunpaweravong S
    J Gastrointest Cancer; 2020 Sep; 51(3):947-951. PubMed ID: 31758468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent chemoradiotherapy combined with enteral nutrition support: a radical treatment strategy for esophageal squamous cell carcinoma patients with malignant fistulae.
    Ma L; Luo GY; Ren YF; Qiu B; Yang H; Xie CX; Liu SR; Liu SL; Chen ZL; Li Q; Fu JH; Liu MZ; Hu YH; Ye WF; Liu H
    Chin J Cancer; 2017 Jan; 36(1):8. PubMed ID: 28077159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphopenia During Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Association with Dosimetric Parameters and Patient Outcomes.
    Xu H; Lin M; Hu Y; Zhang L; Li Q; Zhu J; Wang S; Xi M
    Oncologist; 2021 Mar; 26(3):e425-e434. PubMed ID: 32960471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients.
    Sun Y; Zhang XL; Mao QF; Liu YH; Kong L; Li MH
    Curr Oncol; 2018 Oct; 25(5):e423-e429. PubMed ID: 30464693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma.
    Suzuki Y; Kikuchi D; Hoteya S; Okamura T; Ochiai Y; Hayasaka J; Dan N; Mitsunaga Y; Tanaka M; Odagiri H; Nomura K; Yamashita S; Matsui A; Iizuka T
    Digestion; 2021; 102(4):622-629. PubMed ID: 32992320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion.
    Yoshimizu S; Yoshio T; Ishiyama A; Tsuchida T; Horiuchi Y; Omae M; Hirasawa T; Asari T; Chin K; Fujisaki J
    Dig Liver Dis; 2018 Aug; 50(8):833-838. PubMed ID: 29477349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
    Chen M; Shen M; Lin Y; Liu P; Liu X; Li X; Li A; Yang R; Ni W; Zhou X; Zhang L; Xu B; Lin J; Chen J; Tian Y
    Radiat Oncol; 2018 Aug; 13(1):150. PubMed ID: 30111361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and prognostic factors of patients with esophageal fistula in advanced esophageal squamous cell carcinoma.
    Guan X; Liu C; Zhou T; Ma Z; Zhang C; Wang B; Yao Y; Fan X; Li Z; Zhang Y
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre- versus postoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
    Hsu PK; Chen HS; Liu CC; Huang CS; Hsieh CC; Hsu HS; Wu SC
    J Thorac Cardiovasc Surg; 2017 Aug; 154(2):732-740.e2. PubMed ID: 28457536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.